Get access

New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance

Authors

  • Olivier Rascol MD, PhD,

    Corresponding author
    1. Department of Clinical Pharmacology, Pharmacovigilance Center and Clinical Investigation Center, Toulouse University Hospital, Toulouse, France
    • Department of Clinical Pharmacology, Pharmacovigilance Center and Clinical Investigation Center, Toulouse University Hospital, Toulouse, Cedex France
    Search for more papers by this author
  • Atul Pathak MD,

    1. Department of Clinical Pharmacology, Pharmacovigilance Center and Clinical Investigation Center, Toulouse University Hospital, Toulouse, France
    Search for more papers by this author
  • Haleh Bagheri,

    1. Department of Clinical Pharmacology, Pharmacovigilance Center and Clinical Investigation Center, Toulouse University Hospital, Toulouse, France
    Search for more papers by this author
  • Jean-Louis Montastruc MD, PhD

    1. Department of Clinical Pharmacology, Pharmacovigilance Center and Clinical Investigation Center, Toulouse University Hospital, Toulouse, France
    Search for more papers by this author

No abstract is available for this article.

Get access to the full text of this article

Ancillary